Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0000905148-24-003241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | 2024-11-18 | ATRA | Nguyen AnhCo | Pres, CEO, Dir | S - Sale | $11.20 | -1,664 | 77.5K | -2% | -$18.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | S | D | 1,664 | $11.20 | 77,454 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 18, 2024 and November 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |